Age-associated features of oxidative stress as marker of vascular aging in comorbid course of hypertension and type 2 diabetes mellitus

Abstract

Aim: To evaluate activity of oxidative stress (OS) as marker of vascular aging in different age groups of patients with combined course of arterial hypertension (HT) and type 2 diabetes mellitus (T2DM).

Methods: 126 patients (average age 57.8 ± 6.2 years) with stage II HT and compensated T2DM were divided into 2 subgroups: 2a (n = 59) - aged 45-60 years; 2b (n = 97) - aged 61-75 years; 30 patients with isolated stage II HT (comparison group), 20 practically healthy individuals (control group). The activity of antioxidative [glutathione peroxidase, sulfhydryl groups (SH-groups)] and oxidative [malonic dialdehyde (MDA)], 8-hydroxy-2-deoxyguanosine (8-OH-dG) systems in blood serum, were studied.

Results: A significant increase in MDA levels (P < 0.05) and SH-groups (P < 0.05) compared with healthy volunteers was observed. Patients in 2b group had lower MDA values than in 2a (6.25 ± 0.33 μmol/L, 7.07 ± 0.44 μmol/L, respectively, P > 0.05). In the 2b group, in comparison with 2a patients, a decrease in thiol status was observed (P > 0.05). The level of 8-OH-dG was increased in patients with HT and T2DM, but there was also an age-associated increase in the average 8-OH-dG in the 2b group.

Conclusion: The age-associated changes in the OS in comorbid course of HT and T2DM did not have significant differences. Nevertheless, the presence of correlations between various indexes that are included in the concept of “vascular aging” and indicators of oxidant-antioxidant systems in different age groups allows us to make an assumption about the significant influence of the oxidative status on the status of vascular age, especially in the older age group persons.

Keywords

Hypertension / type 2 diabetes mellitus / oxidative stress / vascular aging

References

[1] Nilsson PM,Laurent S.Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention.Hypertension2009;54:3-10

[2] Sinkevich DA,Dzyzinsky AA.The concept of vascular age as a new approach to evaluation of cardiovascular risk.Siberian Med J2011;6:9-13(in Russian)

[3] Lakatta EG.Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set up" for vascular disease.Circulation2003;107:139-46

[4] Luchikhina LV,Mendel V.Osteoarthritis and age.Role of aging in the etiology and pathogenesis of the disease. Mod rheumatology2017;11:4-11(in Russian)

[5] Franceschi C,Monti D,Olivieri F,Panourgia MP,Celani L,Cevenini E,Salvioli S.Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans.Mech Ageing Dev2007;128:92-105

[6] Hammad EV, Belousova ON, Khmelnitsky AV, Poltoratsky AN, Shchekaturov AA. Modern biomaterials of aging for stratification of risks associated with development of age-associated diseases (review) // Scientific Bulletins of BelSU. Series: medicine. Available from: https://cyberleninka.ru/article/n/sovremennye-biomaterialy-stareniya-dlya-stratifikatsii-riskov-razvitiya-vozrast-assotsiirovannyh-zabolevaniy-obzor-literatury. [Last accessed on 19 Sep 2018]

[7] Kovalenko VM.Diseases of the circulatory system as a medical and social and socio-political problem (analytical and statistical manual)..2014;Kiev279(in Ukrainian)

[8] Age classification of the World Health Organization. Available from: https://citifox.ru/2016/05/05/vozrastnaya-klassifikaciya-vsemirnoy/. [Last accessed on 19 Sep 201]

[9] Mancia G,Narkiewicz K,Zanchetti A,Christiaens T,De Backer G,Galderisi M,Jaarsma T,Kjeldsen SE,Manolis AJ,Ruilope LM,Sirnes PA,Viigimaa M,Zannad F.2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)..J Hypertens2013;31:1281-357

[10] Ministry of the Health of Ukraine. Order of the Ministry of Health of Ukraine dated 21.12.2012 № 1118 "on approval and implementation of medical-technological documents for the standardization of medical aid in type 2 diabetes". Available from: https://medprosvita.com.ua/nakaz-moz-ukrayini-vid-21-12-2012-n-1118-pro-zatver/. [Last accessed on 19 Sep 2018]

[11] Inzucchi SE,Buse JB,Ferrannini E,Peters AL,Wender R.Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the study of diabetes.Diabetes Care2015;38:140-9

[12] Arutyunov AV,Zybina N.N Methods for assessing free radical oxidation and the body's antioxidant system. Guidelines. St..2000;PetersburgIKF "Foliant"104(in Russian)

[13] Stein JH,Aeschlimann SE,McBride PE.Vascular age: integrating carotid intima-media thickness measurements with global coronary risk assessment.Clin Cardiol2004;27:388-92

[14] Ostroumova OD,Erofeeva AG.Thickness of carotid arteries intima-media complex in patients with H - the possibility of a fixed combination Logimax.Rus Med J2009;8:548(in Russian)

[15] E.A.Prochorovich. Hypotensive therapy: a new combination and new possibilities. Consilium Medicum2013;10:121-5

[16] Esteghamati Alireza,Mirmiranpour Hossein,Mousavizadeh Mostafa,Nakhjavan Manouchehr.Randomized clinical trial: the effect of metformin on markers of oxidative stress and antioxidant reserves in patients with newly diagnosed type 2 diabetes.Obes Metabolism2012;3:41-2

[17] Lodovici M,Luceri C,Rotella CM.Gender-related drug effect on several markers of oxidation stress in diabetes patients with and without complications.Eur J Pharmacol2015;766:86-90

[18] Carracedo J,Martínez de Toda I,Alique M,Ramírez-Chamond R.Protein carbamylation: a marker reflecting increased age-related cell oxidation.Int J Mol Sci2018;

[19] Wu LL,Chang PY.Urinary 8-OH-dG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics.Clin Chim Acta2004;339:1-9

[20] Wang CC,Liou SH.P081 The difference between plasma and urinary 8-hydroxy-2-deoxyguanosine biomarkers measured by liquid chromatrography tandem mass spectrometry.Occup Environ Med2016;73:A147